Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00485654 · ClinicalTrials.gov registry record
Racial Distribution of Heterotaxy Syndrome
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Terminated
- Registry status
- 65
- Enrollment target
NCT00485654 is a clinical trial that was terminated before completion, run by Children's Healthcare of Atlanta. The registered enrollment target is 65 participants.
The verdict
NCT00485654 was terminated before completion, sponsored by Children's Healthcare of Atlanta.
- TERMINATED
- Registry status
- 65 participants
- Enrollment target
Study Summary
Heterotaxy syndrome is a heterogeneous disease that is the result of a failure of normal right-left lateralization of the abdominal and thoracic organs during development. The major clinical manifestations include intestinal malrotation, functional asplenia and complex cyanotic heart disease. Hypothesis: There exists a yet, un-recognized, racial distribution in heterotaxy syndrome.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 1990-01 |
| Est. Completion | 2008-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00485654
The ClinicalTrials.gov registry entry for NCT00485654 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Healthcare of Atlanta, which has 80 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00485654 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00485654 about?
NCT00485654 is a clinical study titled "Racial Distribution of Heterotaxy Syndrome". Heterotaxy syndrome is a heterogeneous disease that is the result of a failure of normal right-left lateralization of the abdominal and thoracic organs during development. The major clinical manifestations include intestinal malrotation, functional asplenia and complex cyanotic heart disease. Hypot...
What is the current status of trial NCT00485654?
This trial is currently terminated. The enrollment target is 65 participants. The study started on 1990-01. Estimated completion is 2008-02.
Who is sponsoring clinical trial NCT00485654?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.